Page last updated: 2024-12-06

meseclazone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

meseclazone: 2-methyl analog of seclazone; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID34445
CHEMBL ID2104738
SCHEMBL ID43495
MeSH IDM0048368

Synonyms (43)

Synonym
2h,9h-isoxazolo[3,2-b][1,3]benzoxazin-9-one, 7-chloro-3,3a-dihydro-2-methyl-
7-chloro-2-methyl-3,3a-dihydro-2h-isoxazolo[3,2-b][1,3]benzoxazin-9-one
meseclazona [inn-spanish]
2h,9h-isoxazolo(3,2-b)(1,3)benzoxazin-9-one, 7-chloro-3,3a-dihydro-2-methyl-
meseclazone [usan:inn]
2h,9h-isoxazolo(3,2-b)(1,3)benzoxacin-9-one, 7-chloro-3,3a-dihydro-2-methyl-
2h,9h-isoxazolo(3,2-b)(1,3)benzoxazin-9-one, 3,3a-dihydro-7-chloro-2-methyl-
7-chloro-2-methyl-3,3a-dihydro-2h,9h-isoxazolo(3,2-b)(1,3)benzoxazin-9-one
7-chloro-3,3a-dihydro-2-methyl-2h,9h-isoxazolo(3,2-b)(1,3)benzoxazin-9-one
meseclazonum [inn-latin]
nsc 297623
meseclazone
2h,2-b][1,3]benzoxacin-9-one, 7-chloro-3,3a-dihydro-2-methyl-
w 2395
w-2395 ,
29053-27-8
nsc-297623
2h,2-b][1,3]benzoxazin-9-one, 7-chloro-3,3a-dihydro-2-methyl-
nsc297623
meseclazone (usan/inn)
D04941
7-chloro-2-methyl-3,3a-dihydro-2h-[1,2]oxazolo[3,2-b][1,3]benzoxazin-9-one
CHEMBL2104738
meseclazonum
meseclazona
unii-51kft71thg
51kft71thg ,
SCHEMBL43495
2h,9h-isoxazolo(3,2-.beta.)(1,3)benzoxacin-9-one, 7-chloro-3,3a-dihydro-2-methyl-
meseclazone [inn]
meseclazone [usan]
7-chloro-3,3a-dihydro-2-methyl-2h,9h-isoxazolo(3,2-.beta.)(1,3)benzoxazin-9-one
OJGJQQNLRVNIKE-UHFFFAOYSA-N
7-chloro-2-methyl-3,3a-dihydro-2h,9h-isoxazolo (3,2-b) (1,3) benzoxazin-9-one
7-chloro-2-methyl-3,3a-dihydro-2h, 9h-isoxazolo (3,2-b) (1,3) benzoxazin-9-one
CS-7203
HY-U00157
7-chloro-3,3a-dihydro-2-methyl-2h,9h-isoxazolo-(3,2-b)(1,3)-benzoxazin-9-one
Q6821182
malvidin-3-o-galactosidechloride
w2395;nsc297623
DTXSID70865466
AKOS040742317
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.66 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]